×
Hypermarcas Total Assets 2010-2025 | HYPMY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Hypermarcas total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
View More
Hypermarcas Total Assets 2010-2025 | HYPMY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Hypermarcas total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
Related Stocks
Company Name
Market
Cap
Chugai Pharmaceutical (CHGCY)
$76.3B
Zoetis (ZTS)
$66.2B
Takeda Pharmaceutical (TAK)
$45.9B
Daiichi Sankyo, - (DSNKY)
$45.5B
BeOne Medicines - (ONC)
$32.3B
Sandoz Group AG (SDZNY)
$25B
Summit Therapeutics (SMMT)
$19.5B
Merck (MKKGY)
$16.7B
Shionogi (SGIOY)
$14.2B
United Therapeutics (UTHR)
$13.2B
Neurocrine Biosciences (NBIX)
$13.1B
Orion OYJ (ORINY)
$11B
IPSEN (IPSEY)
$10.5B
Stevanato Group S.p.A (STVN)
$7.5B
Corcept Therapeutics (CORT)
$7.5B
Madrigal Pharmaceuticals (MDGL)
$7.4B
Grifols, S.A (GRFS)
$6.8B
Ionis Pharmaceuticals (IONS)
$6.6B
Hikma Pharmaceuticals Plc (HKMPF)
$6.2B
Ono Pharmaceutical (OPHLF)
$5.2B
Soleno Therapeutics (SLNO)
$4.4B
Crinetics Pharmaceuticals (CRNX)
$2.9B
Catalyst Pharmaceuticals (CPRX)
$2.6B
AMNEAL PHARMACEUTICALS, INC (AMRX)
$2.5B
NewAmsterdam Pharma (NAMS)
$2.5B
Centessa Pharmaceuticals (CNTA)
$2.1B
Ocular Therapeutix (OCUL)
$1.8B
BioCryst Pharmaceuticals (BCRX)
$1.8B
ARS Pharmaceuticals (SPRY)
$1.8B
Endo (NDOI)
$1.6B